MD - CIK 0000893949
Pediatrix Medical Group, Inc. trades as MD and has a market capitalization of $1.98 B, making it the #2114 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.91B, down 4.9% from the prior year and net income of $165.39M. This page tracks Pediatrix Medical Group, Inc. through 1,444 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Pediatrix Medical Group, Inc.'s revenue declined from $3.18B to $1.91B, a compound annual decline rate of 5.5%. Net profit margin compressed from 10.2% to 8.6% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Employee stock plan | S-8 | 2026-05-21 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
The largest companies sharing Pediatrix Medical Group, Inc.'s SEC industry classification (services-hospitals).
Pediatrix Medical Group, Inc. (MD) has a market capitalization of $1.98 B as of 2026-06-11, ranking #2114 among US-listed companies.
Pediatrix Medical Group, Inc. reported revenue of $1.91B for fiscal year 2025, a decrease of 4.9% year over year.
Yes. Pediatrix Medical Group, Inc. reported net income of $165.39M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.